Paul Campbell
Comptroller/Controller/Auditor en VIATRIS INC. .
Fortuna: 2 M $ al 30/04/2024
Cargos activos de Paul Campbell
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
VIATRIS INC. | Comptroller/Controller/Auditor | 16/11/2020 | - |
Historial de carrera de Paul Campbell
Antiguos cargos conocidos de Paul Campbell.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Comptroller/Controller/Auditor | - | - |
Director Financiero/CFO | - | - |
Estadísticas
Internacional
Reino Unido | 2 |
Estados Unidos | 2 |
Operativa
Comptroller/Controller/Auditor | 2 |
Director of Finance/CFO | 1 |
Sectorial
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
VIATRIS INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Paul Campbell
- Experiencia